Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: Results of the postmarketing observational studies with moclobemide, a reversible MAO-A inhibitor

International Journal of Psychiatry in Clinical Practice

Volumn 3, Issue 4, 1999, Pages 257-264

  Philipp, M ^a,f   Delini Stula, A ^e   Baier, D ^b   Kohnen, R ^c   Scholz, H J ^b   Laux, G ^d  

^a District Hospital   (Germany)

^b ROCHE INNOVATION CENTER MUNICH   (Germany)

^c Inst Med Res Mgmt and Biometr   (Germany)

^d District Hospital Gabersee   (Germany)

^e CNS Medical Research Counseling   (Switzerland)

^f Bezirkskrankenhaus Landshut   (Germany)

Author keywords

Depression; MAO A inhibitors; Moclobemide; Sexual dysfunction

Indexed keywords

MOCLOBEMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; GERMANY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TREATMENT OUTCOME;

EID: 0033400870     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.3109/13651509909068393     Document Type: Article

References (16)

1. Monteiro WO, Noshirvani HF, Marks IM, Lelliot PT (1987) Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial. Br J Psychiatry 151: 107-112.
2. Baier D, Philipp M (1994) Die Beeinflussung sexueller Funktionen durch Antidepressiva. Fortschr Neurol Psychiat 62: 14-20.
3. Simpson GM, Blair JH, Amuso D (1965) Effects of antidepressants on genitourinary function. Dis Nerv Syst 26: 787-9.
4. Kowalski A, Stanley RO, Dennerstein L et al (1985) The sexual side-effects of antidepressant medication: a double blind comparison of two antidepressants in a non-psychiatric population. Br J Psychiatry 147: 413-8.
5. Steiger A (1987) Effects of clomipramine on sleep EEG and nocturnal tumescence (NPT): a long term study in healthy man. J Clin Psychopharmacol 8: 349-54.
6. Steiger A, Holsboer F, Benkert O (1988) Long term studies on the effect of tricyclic antidepressants and selective MAO-A inhibitors on sleep, nocturnal penile tumescence and hormonal secretion in normal controls. In Sleep (ed. WP Koella), 335-7. GF Verlag, Stuttgart.
7. Lane RM (1997) A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management. J Psychopharmacol 11: 72-82.
8. Rothschild AJ (1995) Selective reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 152: 1514-6.
9. Feiger A, Kiev A, Shrivastava RK et al (1996) Nefazodone versus sertraline in outpatients with major depression: focus of efficacy, tolerability and effects on sexual function and satisfaction. J Clin Psychiatry 57 (suppl 2): 53-62.
10. Ferguson JM (1996) Effects of double-blind treatment with nefazodone or sertraline on reemergence of sexual dysfunction in patients with major depressive disorder. Bristol-Myers Squibb Satellite Symposium: Sexual Function in Depression, XXth CINP Congress, Melbourne, Australia.
11. Hilton S, Jaber B, Ruch R (1995) Moclobemide safety: monitoring a newly developed product in the 1990s. J Clin Psychopharmacol 15 (suppl 2): 76S-83S.
12. Kennedy SH, Ralevski E, Davis C, Neitzert C (1996) The effects of moclobemide on sexual desire and function in healthy volunteers. Eur Neuropsychopharmacol 6: 177-81.
13. Versiani M, Nardi AE, Mundim FD et al (1996) The long-term treatment of social phobia with moclobemide. Int Clin Psychopharmacol 11 (suppl 3): 83-8.
14. Philipp M, Kohnen R, Benkert O (1993) A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int Clin Psychopharmacol 7: 123-32.
15. Lauerma H (1995) A case of moclobemide-induced hyper-orgasmia. Int Clin Psychopharmacol 10: 123-4.
16. Montejo AL, Llorca G, Izquierdo JA (1996) Sexual dysfunction with SSRIs: A comparative analysis. Abstract, American Psychiatric Association 149th annual meeting.